CT HB05053

Permits licensed health care professionals to prescribe or dispense opioid antagonists (naloxone) without liability, and allows any person in good faith to administer such drugs during an overdose emergency without legal consequences.

Requires municipalities to ensure emergency responders and first responders are equipped with opioid antagonists and receive training in their administration by October 1, 2016.

Eliminates prior authorization requirements for naloxone and other FDA-approved overdose reversal drugs on individual and group health insurance policies effective January 1, 2017.

Limits initial opioid prescriptions to a seven-day supply for adults and minors, with exceptions for chronic pain, cancer-related pain, palliative care, and acute medical conditions documented in medical records.

Establishes an electronic prescription drug monitoring program requiring pharmacies and dispensers to report controlled substance prescriptions to track and prevent improper opioid use.